Charles River Laboratories International Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Charles River Laboratories International Inc 公司

Charles River Laboratories International, Inc. 提供基本產品和服務，幫助全球製藥和生物技術公司、政府機構和學術機構加速其研究和藥物開發工作。該公司的研究模型和服務部門由三項業務組成，提供基礎工具，使其客戶能夠發現新分子：研究模型、研究模型服務和細胞解決方案。其發現和安全評估部門提供受監管和非受監管的 DSA 服務，以支持潛在新藥的研究、開發和監管要求的安全測試，包括治療發現和優化以及體外和體內研究、實驗室支持服務以及戰略非臨牀諮詢和項目管理，以支持產品開發。其製造解決方案部門包括微生物解決方案和生物製劑解決方案。

公司簡介

公司代碼CRL

公司名稱Charles River Laboratories International Inc

上市日期Jun 23, 2000

成立日期1994

CEOMr James C. Foster

員工數量18600

證券類型Ordinary Share

年結日Jun 23

公司地址251 Ballardvale St

城市WILMINGTON

上市交易所NYSE Consolidated

國家United States of America

郵編01887

電話17812226000

網址https://www.criver.com/

公司代碼CRL

上市日期Jun 23, 2000

成立日期1994

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr James C. Foster

Chairman of the Board, President, Chief Executive Officer

250.71K

+1.11%

Ms. Birgit Girshick

Chief Operating Officer, Corporate Executive Vice President

46.41K

-3.11%

Mr. Robert J. (Bob) Bertolini, CPA

Independent Director

32.80K

--

Ms. Victoria L. (Vicky) Creamer

Corporate Executive Vice President, Chief People Officer

12.03K

-27.10%

Mr. Joseph W. LaPlume

Corporate Executive Vice President - Corporate Development and Strategy

8.38K

-4.21%

Dr. Deborah Turner Kochevar, Ph.D.

Independent Director

7.89K

--

Ms. Shannon M. Parisotto

Corporate Executive Vice President - Discovery and Safety Assessment Management

7.60K

+20.39%

Mr. George E. Massaro, CPA

Independent Director

5.86K

--

Ms. Virginia M. (Gina) Wilson, CPA

Independent Director

3.96K

--

Dr. Nancy C. Andrews, M.D., Ph.D.

Independent Director

3.02K

--

名稱

名稱/職務

職務

持股

持股變動

Mr James C. Foster

Chairman of the Board, President, Chief Executive Officer

250.71K

+1.11%

Ms. Birgit Girshick

Chief Operating Officer, Corporate Executive Vice President

46.41K

-3.11%

Mr. Robert J. (Bob) Bertolini, CPA

Independent Director

32.80K

--

Ms. Victoria L. (Vicky) Creamer

Corporate Executive Vice President, Chief People Officer

12.03K

-27.10%

Mr. Joseph W. LaPlume

Corporate Executive Vice President - Corporate Development and Strategy

8.38K

-4.21%

Dr. Deborah Turner Kochevar, Ph.D.

Independent Director

7.89K

--

收入明細

單位: USD更新時間: 4月6日週日

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

業務USD

名稱

營收

佔比

DSA

2.45B

60.53%

RMS

829.38M

20.48%

Manufacturing

769.33M

19.00%

地區USD

名稱

營收

佔比

United States

2.24B

55.31%

Europe

1.08B

26.62%

Canada

482.09M

11.90%

Asia Pacific (Region)

196.95M

4.86%

Other

52.82M

1.30%

業務

地區

業務USD

名稱

營收

佔比

DSA

2.45B

60.53%

RMS

829.38M

20.48%

Manufacturing

769.33M

19.00%

股東統計

更新時間: 2月21日週五

持股股東

股東類型

持股股東

股東統計

佔比

The Vanguard Group, Inc.

12.49%

Wellington Management Company, LLP

8.30%

BlackRock Institutional Trust Company, N.A.

6.01%

State Street Global Advisors (US)

4.44%

Kayne Anderson Rudnick Investment Management, LLC

3.68%

Other

65.09%

持股股東

股東統計

佔比

The Vanguard Group, Inc.

12.49%

Wellington Management Company, LLP

8.30%

BlackRock Institutional Trust Company, N.A.

6.01%

State Street Global Advisors (US)

4.44%

Kayne Anderson Rudnick Investment Management, LLC

3.68%

Other

65.09%

股東類型

股東統計

佔比

Investment Advisor/Hedge Fund

51.79%

Investment Advisor

38.24%

Hedge Fund

12.50%

Research Firm

4.86%

Pension Fund

1.55%

Bank and Trust

1.37%

Sovereign Wealth Fund

1.16%

Individual Investor

0.91%

Insurance Company

0.07%

機構持股

更新時間: 1月20日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q1

1384

55.02M

112.00%

-3.67M

2024Q4

1423

54.85M

107.26%

-4.35M

2024Q3

1392

53.78M

105.14%

-5.12M

2024Q2

1399

54.00M

104.84%

-4.00M

2024Q1

1393

53.76M

104.37%

-4.04M

2023Q4

1424

53.56M

104.42%

-4.24M

2023Q3

1446

53.56M

104.42%

-3.98M

2023Q2

1427

52.88M

103.32%

-3.95M

2023Q1

1431

52.72M

103.01%

-2.79M

2022Q4

1416

51.28M

100.65%

-3.46M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

6.13M

12.49%

+58.13K

+0.96%

Dec 31, 2024

Wellington Management Company, LLP

4.08M

8.3%

+335.66K

+8.97%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

2.95M

6.01%

-51.78K

-1.72%

Dec 31, 2024

State Street Global Advisors (US)

2.18M

4.44%

+51.15K

+2.40%

Dec 31, 2024

Kayne Anderson Rudnick Investment Management, LLC

1.81M

3.68%

-134.28K

-6.92%

Dec 31, 2024

Allspring Global Investments, LLC

1.81M

3.68%

+47.22K

+2.68%

Dec 31, 2024

Geode Capital Management, L.L.C.

1.23M

2.51%

+14.79K

+1.21%

Dec 31, 2024

Impactive Capital LP

1.20M

2.45%

+825.95K

+219.44%

Dec 31, 2024

Meritage Group LP

1.07M

2.19%

-111.05K

-9.37%

Dec 31, 2024

Ariel Investments, LLC

1.07M

2.17%

+169.64K

+18.90%

Dec 31, 2024

持股ETF

更新時間: 4月6日週日

機構名稱

佔比

First Trust NASDAQ Pharmaceuticals ETF

2.3%

Janus Henderson Small/Mid Cap Growth Alpha ETF

2.1%

Schwab Ariel ESG ETF

1.64%

First Trust Health Care Alphadex Fund

1.55%

VanEck Biotech ETF

1.44%

Invesco S&P 500 Equal Weight Health Care ETF

1.35%

ROBO Global Healthcare Technology & Innovation ETF

1.34%

Franklin Genomic Advancements ETF

1.25%

Hilton Small-MidCap Opportunity ETF

1.07%

Amplify AI Powered Equity ETF

1.02%

First Trust NASDAQ Pharmaceuticals ETF

佔比2.3%

Janus Henderson Small/Mid Cap Growth Alpha ETF

佔比2.1%

Schwab Ariel ESG ETF

佔比1.64%

First Trust Health Care Alphadex Fund

佔比1.55%

VanEck Biotech ETF

佔比1.44%

Invesco S&P 500 Equal Weight Health Care ETF

佔比1.35%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.34%

Franklin Genomic Advancements ETF

佔比1.25%

Hilton Small-MidCap Opportunity ETF

佔比1.07%

Amplify AI Powered Equity ETF

佔比1.02%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Charles River Laboratories International Inc

116.820USD

Charles River Laboratories International Inc

116.820

概覽

公司